Profile
Todd D.
C.
Anderman worked as a Corporate Attorney at Cravath, Swaine & Moore LLP from 2007 to 2012.
He also worked as Secretary, Vice President & General Counsel at IVERIC bio, Inc. Mr. Anderman graduated from The University of Pennsylvania Law School with a graduate degree and from Cornell University College of Arts & Sciences with an undergraduate degree.
Former positions of Todd Anderman
| Companies | Position | End |
|---|---|---|
Cravath, Swaine & Moore LLP
 Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Cravath, Swaine & Moore LLP provides legal services. The firm's practice areas encompasses corporate, executive compensation and benefits, international business, litigation, pro bono, tax, and trusts and estates. Its lawyers and associates' training focus on addressing and handling clients' legal issues, business transaction, and disputes. The company was founded in 1819 and is headquartered in New York, NY. | Corporate Officer/Principal | 01/04/2012 |
| IVERIC BIO, INC. | General Counsel | - |
Training of Todd Anderman
| The University of Pennsylvania Law School | Graduate Degree |
| Cornell University College of Arts & Sciences | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 2 |
|---|---|
Cravath, Swaine & Moore LLP
Cravath, Swaine & Moore LLP Miscellaneous Commercial ServicesCommercial Services Cravath, Swaine & Moore LLP provides legal services. The firm's practice areas encompasses corporate, executive compensation and benefits, international business, litigation, pro bono, tax, and trusts and estates. Its lawyers and associates' training focus on addressing and handling clients' legal issues, business transaction, and disputes. The company was founded in 1819 and is headquartered in New York, NY. | Commercial Services |
IVERIC bio, Inc.
 IVERIC bio, Inc. Pharmaceuticals: GenericHealth Technology IVERIC bio, Inc. operates as a biopharmaceutical company. The firm engages in discovering, developing and commercializing novel therapeutics to treat ophthalmic diseases, with a focus on age-related and orphan retinal diseases. Its product candidates include Zimura and Gene Therapy. The company was founded by David R. Guyer and Samir Chandrakant Patel on January 5, 2007 and is headquartered in Parsippany, NJ. | Health Technology |
- Stock Market
- Insiders
- Todd Anderman
